HEIDELBERG PHARMA HOLDING GMBH has a total of 37 patent applications. Its first patent ever was published in 1993. It filed its patents most often in EPO (European Patent Office), Czechia and Finland. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are PHARMAXIS PTY LTD, BAKER STEPHEN J and ALIHODZIC SULEJMAN.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 9 | |
#2 | Czechia | 4 | |
#3 | Finland | 4 | |
#4 | Hungary | 4 | |
#5 | Poland | 3 | |
#6 | Argentina | 2 | |
#7 | Germany | 2 | |
#8 | Israel | 2 | |
#9 | Japan | 2 | |
#10 | China | 1 | |
#11 | Norway | 1 | |
#12 | Slovakia | 1 | |
#13 | United States | 1 | |
#14 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines | |
#4 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Herrmann Dieter | 23 |
#2 | Zilch Harald | 19 |
#3 | Opitz Hans-Georg | 13 |
#4 | Mertens Alfred | 7 |
#5 | Zimmermann Gerd | 6 |
#6 | Wirl Alexander | 5 |
#7 | Gabel Rolf-Dieter | 5 |
#8 | Woog Heinrich | 4 |
#9 | Voss Edgar | 3 |
#10 | Kiegel Einhard | 2 |
Publication | Filing date | Title |
---|---|---|
EP1460082A1 | Phospholipid esters of clofarabine derivatives | |
EP1448579A1 | Phospholipid derivatives of nucleosides as antitumoral medicaments | |
JP2004026727A | Phospholipid derivative of nucleoside as antitumor medicine | |
DE10209564A1 | Antitumoral and antineoplastic medicaments, effective against carcinoma, sarcoma, lymphoma and leukemia, comprise new or known nucleoside-sulfur containing phospholipid derivatives | |
DE10156910A1 | Antitumoral and antineoplastic medicaments, effective against carcinoma, sarcoma, lymphoma and leukemia, comprise new or known nucleoside-sulfur containing phospholipid derivatives |